Neuroblastoma 1

Common Name(s)

Neuroblastoma 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroblastoma 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroblastoma 1" returned 153 free, full-text research articles on human participants. First 3 results:

HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
 

Author(s): Anna Lisa Furfaro, Sabrina Piras, Mario Passalacqua, Cinzia Domenicotti, Alessia Parodi, Daniela Fenoglio, Maria Adelaide Pronzato, Umberto Maria Marinari, Lorenzo Moretta, Nicola Traverso, Mariapaola Nitti

Journal: Biochim. Biophys. Acta. 2014 Apr;1842(4):613-22.

 

High-risk neuroblastoma (NB) is characterized by the development of chemoresistance, and bortezomib (BTZ), a selective inhibitor of proteasome, has been proposed in order to overcome drug resistance. Considering the involvement of the nuclear factor-erythroid-derived 2-like 2 (Nrf2) ...

Last Updated: 24 Feb 2014

Go To URL
Oxidative stress enhances neurodegeneration markers induced by herpes simplex virus type 1 infection in human neuroblastoma cells.
 

Author(s): Soraya Santana, Isabel Sastre, Maria Recuero, Maria J Bullido, Jesus Aldudo

Journal:

 

Mounting evidence suggests that Herpes simplex virus type 1 (HSV-1) is involved in the pathogenesis of Alzheimer's disease (AD). Previous work from our laboratory has shown HSV-1 infection to induce the most important pathological hallmarks of AD brains. Oxidative damage is one of ...

Last Updated: 14 Oct 2013

Go To URL
Effect of heavy metals on silencing of engineered long interspersed element-1 retrotransposon in nondividing neuroblastoma cell line.
 

Author(s): Laleh Habibi, Mohammad Ali Shokrgozar, Mahdieh Motamedi, Seyed Mohammad Akrami

Journal: Iran. Biomed. J.. 2013 ;17(4):171-8.

 

L1 retrotransposons are the most active mobile DNA elements in human genome. Unregulated L1 retrotransposition may have deleterious effect by disrupting vital genes and inducing genomic instabilities. Therefore, human cells control L1 elements by silencing their activities through ...

Last Updated: 3 Sep 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroblastoma 1" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

High Risk Neuroblastoma Study 1 (1.5) of SIOP-Europe (SIOPEN)
 

Status: Recruiting

Condition Summary: Neuroblastoma

 

Last Updated: 10 Oct 2012

Go to URL

Last Updated: 7 Jan 2014

Go to URL
Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
 

Status: Recruiting

Condition Summary: Recurrent or Refractory Solid Tumors; Ewing Sarcoma; Rhabdomyosarcoma; Neuroblastoma; Osteosarcoma

 

Last Updated: 21 Jan 2014

Go to URL